Aduro Clean Technologies gibt das Datum des Inkrafttretens der Aktienkonsolidierung und der Umwandlung von Sonder-Warrants der Klasse B bekannt
August 16, 2024 22:00 ET
|
Aduro Clean Technologies Inc.
LONDON, Ontario, Aug. 17, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro“ oder das „Unternehmen“) (CSE: ACT) (OTCQX: ACTHF) (FSE: 9D50), ein kanadisches Technologieunternehmen, das...
Aduro Clean Technologies annonce la date d’entrée en vigueur de la consolidation des actions et de la conversion des bons de souscription spéciaux de catégorie B
August 16, 2024 22:00 ET
|
Aduro Clean Technologies Inc.
LONDON, Ontario, 17 août 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (« Aduro » ou la « Société ») (CSE : ACT) (OTCQX : ACTHF) (FSE : 9D50), une société technologique canadienne qui...
Cannara Biotech atteint sa part de marché nationale la plus élevée, soit 3,2 %, en juillet 2024 et annonce la tenue d’une webdiffusion pour les investisseurs le 20 août 2024
August 16, 2024 20:25 ET
|
Cannara Biotech (Québec) Inc.
MONTRÉAL, 16 août 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara » ou la « Société ») (TSXV : LOVE) (OTCQB : LOVFF) (FRA : 8CB0), un producteur verticalement intégré de cannabis...
Blender Bites Files Amended and Restated Offering Document for Private Placement
August 16, 2024 19:07 ET
|
Blender Bites Limited
Blender Bites Files Amended and Restated Offering Document
for Private Placement
Lifeist Announces Acquisition of High-Potency Vape IP
August 16, 2024 16:34 ET
|
Lifeist Wellness Inc.
TORONTO, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders
August 16, 2024 16:14 ET
|
Clearmind Medicine Inc.
Vancouver, Canada, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "company"), a biotech company focused on discovery and development of...
Amcomri Announces Delay in Q2 Filings
August 16, 2024 14:00 ET
|
Amcomri Entertainment Inc.
VANCOUVER, British Columbia, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Amcomri Entertainment Inc. (“Amcomri” or the “Company”) (Cboe CA: AMEN) (Frankfurt: 25YO) (OTC: AMNNF) announces a delay in the filing...
Osino and Shanjin (Formerly Yintai) Obtain Namibian Competition Approval and Confirm Closing Date in Connection With Shanjin Transaction
August 16, 2024 11:00 ET
|
Osino Resources Corp.
VANCOUVER, British Columbia, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Osino Resources Corp. (TSX:OSI.V) (NSX:OSN) (FSE:RSR1) (OTCQX:OSIIF) ("Osino" or the "Company") is pleased to announce that, in...
Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024
August 16, 2024 09:00 ET
|
Cannara Biotech (Québec) Inc.
Cannara Biotech announces record-breaking July revenues and schedules an investor webcast for August 20, 2024. Join at 2 PM ET for Q3 updates and a live QA
Nevada Lithium Announces Closing of $6 Million Private Placement led by Strategic Investor Marcel Boekhoorn
August 16, 2024 08:00 ET
|
Nevada Lithium Resources Inc.
VANCOUVER, British Columbia, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Nevada Lithium Resources Inc. (CSE: NVLH; OTCQB: NVLHF; FSE: 87K) (“Nevada Lithium” or the “Company”) is pleased to announce that it...